Measurement of non-Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology
出版年份 2014 全文链接
标题
Measurement of non-Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 166, Issue 6, Pages 830-841
出版商
Wiley
发表日期
2014-06-17
DOI
10.1111/bjh.12975
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
- (2013) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Correlating prothrombin time with plasma rivaroxaban level
- (2013) Ryan Rodgers et al. BRITISH JOURNAL OF HAEMATOLOGY
- More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban - early experience from King's College Hospital
- (2013) Jignesh P. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Frequent False-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin
- (2013) M. E. Martinuzzo et al. International Journal of Laboratory Hematology
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels
- (2013) E. M. Hawes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
- (2013) T. Baglin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions
- (2013) H. Mani et al. THROMBOSIS AND HAEMOSTASIS
- Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
- (2013) Christian Chatelain et al. THROMBOSIS AND HAEMOSTASIS
- Measuring Direct Thrombin Inhibitors With Routine and Dedicated Coagulation Assays
- (2012) Joyce Curvers et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Effect of Dabigatran on Select Specialty Coagulation Assays
- (2012) Dorothy M. Adcock et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Dabigatran Effects on the International Normalized Ratio, Activated Partial Thromboplastin Time, Thrombin Time, and Fibrinogen: A Multicenter, In Vitro Study
- (2012) William E Dager et al. ANNALS OF PHARMACOTHERAPY
- Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology
- (2012) Trevor Baglin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Parenteral Anticoagulants
- (2012) David A. Garcia et al. CHEST
- Executive Summary
- (2012) Gordon H. Guyatt et al. CHEST
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Treatment and Prevention of Heparin-Induced Thrombocytopenia
- (2012) Lori-Ann Linkins et al. CHEST
- Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests
- (2012) Walter-Michael Halbmayer et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
- (2012) I. Mackie et al. International Journal of Laboratory Hematology
- Dabigatran: laboratory monitoring
- (2012) Simon D.F. Jones et al. PATHOLOGY
- Determination of Dabigatran in Human Plasma Samples
- (2012) Job Harenberg et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Impact of dabigatran on a large panel of routine or specific coagulation assays
- (2012) Séverine Robert et al. THROMBOSIS AND HAEMOSTASIS
- Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin
- (2012) Gabriele Rohde et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran Falsely Elevates Point of Care International Normalized Ratio Results
- (2011) Christina E. DeRemer et al. AMERICAN JOURNAL OF MEDICINE
- Argatroban Therapy Using Enzymatic Anti-Factor IIa Monitoring
- (2011) Michele F Shepherd et al. ANNALS OF PHARMACOTHERAPY
- Potential Inaccuracy of Point-of-Care INR in Dabigatran-Treated Patients
- (2011) Lawrence Baruch et al. ANNALS OF PHARMACOTHERAPY
- Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study
- (2011) J. A. Heit et al. BLOOD
- Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban
- (2011) Job Harenberg et al. BLOOD COAGULATION & FIBRINOLYSIS
- Guidelines on oral anticoagulation with warfarin - fourth edition
- (2011) David Keeling et al. BRITISH JOURNAL OF HAEMATOLOGY
- Laboratory assessment of new anticoagulants
- (2011) Meyer M. Samama et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- UPLC MS/MS assay for routine quantification of dabigatran – A direct thrombin inhibitor – In human plasma
- (2011) Xavier Delavenne et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time
- (2011) Christian Hesse et al. THROMBOSIS AND HAEMOSTASIS
- Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement
- (2011) Geneviève Freyburger et al. THROMBOSIS RESEARCH
- Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests
- (2011) L.M. Asmis et al. THROMBOSIS RESEARCH
- Monitoring of the Anticoagulants Argatroban and Lepirudin
- (2010) Boris Ivandic et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- New oral antithrombotics: a need for laboratory monitoring. For
- (2010) P. MISMETTI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- New oral antithrombotics: a need for laboratory monitoring. Against
- (2010) H. BOUNAMEAUX et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Monitoring new oral antithrombotics: what we should know before we can decide
- (2010) R. AL DIERI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study
- (2010) A. TRIPODI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
- (2010) A. HILLARP et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome
- (2010) John Alexander et al. THROMBOSIS AND HAEMOSTASIS
- Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
- (2010) Zhaoqing Wang et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
- (2010) Jean-Luc Martinoli et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban and false positive lupus anticoagulant testing
- (2010) Zane Kaplan et al. THROMBOSIS AND HAEMOSTASIS
- Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
- (2010) Fariba Baghaei et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prothrombinase-Induced Clotting Time Assay for Determination of the Anticoagulant Effects of Unfractionated and Low-Molecular-Weight Heparins, Fondaparinux, and Thrombin Inhibitors
- (2008) Andreas Calatzis et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction
- (2008) Robert Siegmund et al. BLOOD COAGULATION & FIBRINOLYSIS
- The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia
- (2008) S. Guy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Parenteral Anticoagulants
- (2008) Jack Hirsh et al. CHEST
- Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies
- (2008) P. C. WONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): Relation to FXa-activity and influence of assay modifications
- (2008) Sebastian Harder et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started